FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117013534> ?p ?o ?g. }

• W2117013534 endingPage "1221" @default.
• W2117013534 startingPage "1207" @default.
• W2117013534 abstract "Objective: To review the evidence base supporting the use of salicylates for glucose level control in patients with type 2 diabetes and provide a comprehensive review of available information describing the potential role of salicylates and, in particular, salsalate, for glucose control in type 2 diabetes prevention and treatment. DATA SOURCES: A literature search using MEDLINE (1966–March 2010), PubMed, and Google Scholar was conducted using the search terms salicylates, salicylic acid, aspirin, salsalate, acetytsalicylic acid, insulin, glucose, glycemic control, diabetes, hyperglycemia, and nuclear factor. The bibliographies of identified articles were reviewed for additional citations. Study Selection and Data Extraction: All relevant English-language information on the pharmacology, efficacy, and safety of salicylates for glucose control related to insulin resistance or diabetes prevention were reviewed. Preclinical data, clinical trials, and case reports were identified, evaluated, and included in this systematic review. Data Synthesis: Treatment of inflammation may be a potential novel strategy in prevention and treatment of type 2 diabetes, in which the body is resistant to the effects of insulin. Previous and recent studies reveal a possible relationship between inflammation and obesity. The chronic activation of the immune system due to low-grade inflammation was found in several studies to be associated with obesity, and this, in turn, can promote development of insulin resistance and impaired glucose tolerance. Administration of salicylates was shown over a century ago to lower glucose levels in patients with diabetes. Many in vitro and in vivo pharmacologic studies have demonstrated a glucose-lowering effect of salicylates. Salicylates, especially salsalate, were found in several clinical studies and case reports to be potential agents for diabetes treatment with a favorable safety profile. Although these studies had inherent limitations, such as small numbers of patients and short duration, the vast majority showed significant glucose-lowering effects. A large randomized trial, the National Institute of Diabetes and Digestive and Kidney Diseases–sponsored Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D) trial, recently concluded that salsalate lowers hemoglobin A 1c levels and improves glycemic control in patients with type 2 diabetes. Conclusions: Salicylates, especially salsalate, appear to be a promising treatment option for prevention or treatment of diabetes by lowering glucose levels. More extensive studies are needed to confirm the mechanisms involved and whether the effects are sustainable with continued administration of these agents. Further studies are warranted." @default.
• W2117013534 created "2016-06-24" @default.
• W2117013534 creator A5077424186 @default.
• W2117013534 creator A5082165587 @default.
• W2117013534 date "2010-06-01" @default.
• W2117013534 modified "2023-10-12" @default.
• W2117013534 title "Potential Role of Salicylates in Type 2 Diabetes" @default.
• W2117013534 cites W153130060 @default.
• W2117013534 cites W1558367558 @default.
• W2117013534 cites W1967724716 @default.
• W2117013534 cites W1968357607 @default.
• W2117013534 cites W1971537221 @default.
• W2117013534 cites W1979906379 @default.
• W2117013534 cites W1981694119 @default.
• W2117013534 cites W1981729776 @default.
• W2117013534 cites W1984598552 @default.
• W2117013534 cites W1985048119 @default.
• W2117013534 cites W1988507837 @default.
• W2117013534 cites W1992655736 @default.
• W2117013534 cites W1993975599 @default.
• W2117013534 cites W1996836418 @default.
• W2117013534 cites W2004329695 @default.
• W2117013534 cites W2008732490 @default.
• W2117013534 cites W2009150561 @default.
• W2117013534 cites W2009588764 @default.
• W2117013534 cites W2011672691 @default.
• W2117013534 cites W2013895711 @default.
• W2117013534 cites W2017035148 @default.
• W2117013534 cites W2022800351 @default.
• W2117013534 cites W2027121992 @default.
• W2117013534 cites W2029778331 @default.
• W2117013534 cites W2031619809 @default.
• W2117013534 cites W2031637294 @default.
• W2117013534 cites W2031882974 @default.
• W2117013534 cites W2034541077 @default.
• W2117013534 cites W2034864003 @default.
• W2117013534 cites W2041909478 @default.
• W2117013534 cites W2045658416 @default.
• W2117013534 cites W2050764448 @default.
• W2117013534 cites W2052613321 @default.
• W2117013534 cites W2054415546 @default.
• W2117013534 cites W2057496021 @default.
• W2117013534 cites W2064119981 @default.
• W2117013534 cites W2064254706 @default.
• W2117013534 cites W2065471896 @default.
• W2117013534 cites W2067225546 @default.
• W2117013534 cites W2077518063 @default.
• W2117013534 cites W2081659092 @default.
• W2117013534 cites W2082916190 @default.
• W2117013534 cites W2086284696 @default.
• W2117013534 cites W2090697965 @default.
• W2117013534 cites W2094544824 @default.
• W2117013534 cites W2097838137 @default.
• W2117013534 cites W2098217678 @default.
• W2117013534 cites W2100079448 @default.
• W2117013534 cites W2102177965 @default.
• W2117013534 cites W2113370437 @default.
• W2117013534 cites W2116610940 @default.
• W2117013534 cites W2117121624 @default.
• W2117013534 cites W2121082844 @default.
• W2117013534 cites W2138551135 @default.
• W2117013534 cites W2144587747 @default.
• W2117013534 cites W2145855378 @default.
• W2117013534 cites W2149591938 @default.
• W2117013534 cites W2149858760 @default.
• W2117013534 cites W2151672809 @default.
• W2117013534 cites W2152211462 @default.
• W2117013534 cites W2152377123 @default.
• W2117013534 cites W2153214557 @default.
• W2117013534 cites W2156393790 @default.
• W2117013534 cites W2159832505 @default.
• W2117013534 cites W2160297973 @default.
• W2117013534 cites W2160516464 @default.
• W2117013534 cites W2165719318 @default.
• W2117013534 cites W2166735617 @default.
• W2117013534 cites W2171165571 @default.
• W2117013534 cites W2331883407 @default.
• W2117013534 cites W2333341135 @default.
• W2117013534 cites W2469307620 @default.
• W2117013534 cites W4246592598 @default.
• W2117013534 doi "https://doi.org/10.1345/aph.1m483" @default.
• W2117013534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20516365" @default.
• W2117013534 hasPublicationYear "2010" @default.
• W2117013534 type Work @default.
• W2117013534 sameAs 2117013534 @default.
• W2117013534 citedByCount "55" @default.
• W2117013534 countsByYear W21170135342012 @default.
• W2117013534 countsByYear W21170135342013 @default.
• W2117013534 countsByYear W21170135342014 @default.
• W2117013534 countsByYear W21170135342015 @default.
• W2117013534 countsByYear W21170135342016 @default.
• W2117013534 countsByYear W21170135342017 @default.
• W2117013534 countsByYear W21170135342018 @default.
• W2117013534 countsByYear W21170135342019 @default.
• W2117013534 countsByYear W21170135342020 @default.
• W2117013534 countsByYear W21170135342021 @default.
• W2117013534 countsByYear W21170135342022 @default.
• W2117013534 countsByYear W21170135342023 @default.

• next